Alzheimer’s
Brain imaging breakthrough predicts Alzheimer's decline in early stages
Posted in Medicine on 3rd Jan, 2020
by Alex Muller
Utilizing a recently developed brain imaging technique new research suggests that measuring accumulated levels of a protein called tau may predict future neurodegeneration associated with Alzihemer’s disease.
Insights into anti-aging properties of experimental Alzheimer’s drug
Posted in Medicine on 11th Dec, 2019
by Alex Muller
Salk researchers have been developing two experimental drugs for several years with a view on improving cognition and slowing the neurodegenerative decline associated with Alzheimer’s disease
The resurrection of a failed Alzheimer’s drug set to test FDA approval process
Posted in Medicine on 9th Dec, 2019
by Alex Muller
Experts are divided on the efficacy data concerning a novel Alzheimer's drug, but it's now up to the FDA to judge whether a controversial Phase 3 trial is enough for market approval
Microbiome-altering Alzheimer’s drug unexpectedly approved in China
Posted in Medicine on 6th Nov, 2019
by Alex Muller
The drug, derived from a marine algae, is the first new Alzheimer’s drug to reach the market anywhere in the world in almost 20 years, and is suggested to reduce neuroinflammation by modulating a person’s gut microbiome.
Infamous 'hunger hormone' linked to memory deficits in Alzheimer’s disease
Posted in Medicine on 5th Sep, 2019
by Alex Muller
If validated by future work, however, this mechanism could be effectively targeted to slow, or even stop, some cognitive decline associated with not just Alzheimer’s disease, but aging on general.